Back to Results
First PageMeta Content
Dosage forms / Non-steroidal anti-inflammatory drugs / Morphinans / Pharmaceutical industry / Tablet / Aspirin / Oxycodone / Hydromorphone / Pharmacology / Chemistry / Medicine


New Zealand Consumer Medicine Information PERSANTIN® 25 mg tablets Dipyridamole tablets This leaflet answers some common questions about PERSANTIN 25 mg tablets. It does not contain all available information. It does n
Add to Reading List

Document Date: 2015-07-14 21:43:21


Open Document

File Size: 52,62 KB

Share Result on Facebook

City

Manukau City / Manukau City Auckland Ph / /

Company

BOEHRINGER INGELHEIM (N.Z.) LIMITED / /

Country

France / New Zealand / /

IndustryTerm

treatment of high blood pressure / treatment of myasthenia gravis / machinery / /

MedicalCondition

allergic reaction / flushing / Headache / hives / nausea / Skin rash / heart disease / thrombocytopenia / blood clots / Lapp lactase deficiency / Low blood pressure / rare hereditary conditions / blister / heart attack / allergic reactions / circulation causing chest pain / Muscle aches / restlessness / high blood pressure / e.g. angina / dizziness / fructose intolerance / such an allergy / severe muscle disease / lightheadedness / myasthenia gravis / /

MedicalTreatment

surgery / /

Organization

Poisons Information Centre / /

/

Position

pharmacist / /

Product

talc / Description What / Storage Leave / Dipyridamole / adenosine / Each PERSANTIN 25 / /

SocialTag